QBTS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
D-Wave Quantum (QBTS) is not a good buy right now for a Beginner with a long-term focus and $50,000-$100,000 to invest. The stock has strong long-term quantum-computing upside and favorable analyst commentary, but the current technical trend is weak and the recent pullback makes the entry unattractive for an impatient buyer. My direct view: hold off for now rather than buying today.
QBTS is in a bearish short-term setup. MACD histogram is negative and still expanding lower, RSI_6 at 39.154 shows weak momentum but not yet oversold, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 22.52 is below the pivot level of 23.736 and above support at 21.528, which means the stock is trading near support but without confirmation of reversal. The recent regular session decline of 4.13% reinforces near-term weakness.
["Jefferies said Trump's executive orders supporting U.S. quantum computing are positive for QBTS and the sector.", "D-Wave received a $1.5M-$1.57M NSF grant tied to the ERASE project, supporting fault-tolerant quantum computing development.", "Recent analyst coverage remains generally constructive, with multiple Buy/Outperform ratings and higher price targets.", "Long-term quantum computing market potential remains large, and D-Wave is viewed as a key industry participant."]
["The stock sold off 4.13% in the regular session, showing immediate pressure.", "Technical trend is bearish: MACD negative, bearish moving averages, and price below pivot.", "There is no AI Stock Picker signal today and no recent SwingMax buy signal.", "Hedge funds and insiders are neutral, with no notable buying trend.", "No recent congress trading data was available to provide a supportive signal.", "The sector is highly competitive, with IonQ, IBM, Rigetti, and others competing intensely."]
No usable financial snapshot was provided because the data returned an error, so I cannot assess the latest quarter revenue or earnings trends. The latest quarter season referenced in the analyst notes is Q1 2026, where analysts said revenue missed expectations but bookings were strong and demand remained clear. That suggests improving commercial traction, but not yet clean quarter-over-quarter financial momentum from the provided data.
Analyst sentiment is mostly positive. Recent notes from Jefferies, Mizuho, B. Riley, Roth Capital, and Canaccord were generally Buy/Outperform with price targets in the $35-$45 range, though some targets were trimmed after modeling updates. Northland is the main more cautious view with a Market Perform rating and $22 target. Overall Wall Street pros see strong long-term potential and commercial progress, but there is still concern about valuation, execution, and competition. The recent trend in analyst actions is upward target revisions and continued bullish coverage, which is a positive backdrop, but it does not change the weak current entry point.
